Literature DB >> 8788067

Immunocytochemical localization of GTP cyclohydrolase I in the brain, adrenal gland, and liver of mice.

I Nagatsu1, H Ichinose, M Sakai, K Titani, M Suzuki, T Nagatsu.   

Abstract

GTP cyclohydrolase I (GCH) is the first and rate-limiting enzyme for the biosynthesis of tetrahydrobiopterin (BH4), the cofactor of phenylalanine, tyrosine, and tryptophan hydroxylases, the enzymes that synthesize tyrosine, catecholamines (dopamine, noradrenaline, and adrenaline), and serotonin, respectively. We produced for the first time polyclonal antibody with highly sensitive immunoreactivity against an oligopeptide of rat enzyme, GEPERELPRPGA, by immunization of rabbits with the peptide conjugated to hemocyanin by glutaraldehyde. The specificity of the antibody was confirmed by Western blot analysis. Using this antibody specific for GCH, we observed strong GCH immunostaining in the liver cells, in the dopamine-, noradrenaline-, adrenaline-, or serotonin-containing cells of the brain, and in the adrenal gland of mice. Immunocytochemical studies revealed GCH to be localized in monoamine-containing perikarya in the periglomerular cells of the olfactory bulb, zona incerta, arcuate nucleus, ventral tegmental area, substantia nigra pars compacta, locus ceruleus, nucleus tractus solitarius, area postrema, and ventrolateral area of the medulla oblongata. GCH immunostaining was particularly strong in serotoninergic nuclei, such as dorsal and median raphe nuclei, nucleus raphe pallidus, and nucleus raphe magnus. By immunoelectron microscopy, GCH-labeled cytoplasm and microtubules in the processes were observed ultrastructurally, but no staining was found in the mitochondria, and Golgi apparatus. Immunostaining was observed neither in the group D neurons that contain only aromatic amino acid decarboxylase without tyrosine hydroxylase, nor in glial cells and endothelial cells. These results indicate the abundant presence of GCH in catecholaminergic and serotoninergic neurons as well as in the adrenal medulla and liver, where BH4 is synthesized as the cofactor of tyrosine, tryptophan, and phenylalanine hydroxylases.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8788067     DOI: 10.1007/bf01281153

Source DB:  PubMed          Journal:  J Neural Transm Gen Sect


  33 in total

1.  TYROSINE HYDROXYLASE. THE INITIAL STEP IN NOREPINEPHRINE BIOSYNTHESIS.

Authors:  T NAGATSU; M LEVITT; S UDENFRIEND
Journal:  J Biol Chem       Date:  1964-09       Impact factor: 5.157

Review 2.  Nitric oxide synthases: roles, tolls, and controls.

Authors:  C Nathan; Q W Xie
Journal:  Cell       Date:  1994-09-23       Impact factor: 41.582

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  Expression in brain sensory neurons of the transgene in transgenic mice carrying human tyrosine hydroxylase gene.

Authors:  I Nagatsu; K Yamada; N Karasawa; M Sakai; T Takeuchi; N Kaneda; T Sasaoka; K Kobayashi; M Yokoyama; T Nomura
Journal:  Neurosci Lett       Date:  1991-06-10       Impact factor: 3.046

5.  Immunohistochemical demonstration of the distribution of serotonin neurons in the brainstem of the rat and cat.

Authors:  Y Takeuchi; H Kimura; Y Sano
Journal:  Cell Tissue Res       Date:  1982       Impact factor: 5.249

6.  Biopterin in human brain and urine from controls and parkinsonian patients: application of a new radioimmunoassay.

Authors:  T Nagatsu; T Yamaguchi; T Kato; T Sugimoto; S Matsuura; M Akino; I Nagatsu; R Iizuka; H Narabayashi
Journal:  Clin Chim Acta       Date:  1981-02-05       Impact factor: 3.786

7.  Multiple mRNA forms of human GTP cyclohydrolase I.

Authors:  A Togari; H Ichinose; S Matsumoto; K Fujita; T Nagatsu
Journal:  Biochem Biophys Res Commun       Date:  1992-08-31       Impact factor: 3.575

8.  Cloning and expression of a cDNA encoding human endothelium-derived relaxing factor/nitric oxide synthase.

Authors:  S P Janssens; A Shimouchi; T Quertermous; D B Bloch; K D Bloch
Journal:  J Biol Chem       Date:  1992-07-25       Impact factor: 5.157

9.  GTP cyclohydrolase I deficiency, a new enzyme defect causing hyperphenylalaninemia with neopterin, biopterin, dopamine, and serotonin deficiencies and muscular hypotonia.

Authors:  A Niederwieser; N Blau; M Wang; P Joller; M Atarés; J Cardesa-Garcia
Journal:  Eur J Pediatr       Date:  1984-02       Impact factor: 3.183

10.  Hyperphenylalaninaemia caused by defects in biopterin metabolism.

Authors:  S Kaufman
Journal:  J Inherit Metab Dis       Date:  1985       Impact factor: 4.982

View more
  10 in total

Review 1.  Serotonin and blood pressure regulation.

Authors:  Stephanie W Watts; Shaun F Morrison; Robert Patrick Davis; Susan M Barman
Journal:  Pharmacol Rev       Date:  2012-03-08       Impact factor: 25.468

Review 2.  Tyrosine hydroxylase replacement in experimental Parkinson's disease with transvascular gene therapy.

Authors:  William M Pardridge
Journal:  NeuroRx       Date:  2005-01

Review 3.  Regulation of pteridine-requiring enzymes by the cofactor tetrahydrobiopterin.

Authors:  T Nagatsu; H Ichinose
Journal:  Mol Neurobiol       Date:  1999-02       Impact factor: 5.590

4.  Partial biopterin deficiency disturbs postnatal development of the dopaminergic system in the brain.

Authors:  Daigo Homma; Chiho Sumi-Ichinose; Hirofumi Tokuoka; Kazuhisa Ikemoto; Takahide Nomura; Kazunao Kondo; Setsuko Katoh; Hiroshi Ichinose
Journal:  J Biol Chem       Date:  2010-11-09       Impact factor: 5.157

Review 5.  Blood-brain barrier transport of non-viral gene and RNAi therapeutics.

Authors:  Ruben J Boado
Journal:  Pharm Res       Date:  2007-06-08       Impact factor: 4.200

6.  Characterization of cerebral microvasculature in transgenic mice with endothelium targeted over-expression of GTP-cyclohydrolase I.

Authors:  Anantha Vijay R Santhanam; Livius V d'Uscio; Zvonimir S Katusic
Journal:  Brain Res       Date:  2015-09-03       Impact factor: 3.252

7.  The Trojan Horse Liposome Technology for Nonviral Gene Transfer across the Blood-Brain Barrier.

Authors:  Ruben J Boado; William M Pardridge
Journal:  J Drug Deliv       Date:  2011-11-16

8.  Alteration of striatal tetrahydrobiopterin in iron-induced unilateral model of Parkinson's disease.

Authors:  Bijay Aryal; Jin-Koo Lee; Hak Rim Kim; Hyung-Gun Kim
Journal:  Korean J Physiol Pharmacol       Date:  2014-04-03       Impact factor: 2.016

Review 9.  The catecholamine system in health and disease -Relation to tyrosine 3-monooxygenase and other catecholamine-synthesizing enzymes.

Authors:  Toshiharu Nagatsu
Journal:  Proc Jpn Acad Ser B Phys Biol Sci       Date:  2007-01-12       Impact factor: 3.493

Review 10.  Brain Kynurenine and BH4 Pathways: Relevance to the Pathophysiology and Treatment of Inflammation-Driven Depressive Symptoms.

Authors:  Sylvie Vancassel; Lucile Capuron; Nathalie Castanon
Journal:  Front Neurosci       Date:  2018-07-24       Impact factor: 4.677

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.